Location History:
- Marseilles, FR (2019)
- Codolet, FR (2019)
Company Filing History:
2 out of 1,744 
2 out of 230 
2 out of 5,089 
Years Active: 2019
Title: Damien Nevoltris: Innovator in Antibody Research
Introduction
Damien Nevoltris is a prominent inventor based in Marseilles, France. He has made significant contributions to the field of therapeutic and diagnostic antibodies. With a total of 2 patents, his work focuses on innovative solutions in medical science.
Latest Patents
His latest patents include "Anti-EGFR conformational single domain antibodies and uses thereof." This invention relates to anti-Epidermal Growth Factor Receptor (EGFR) conformational single domain antibodies, particularly in therapeutic and diagnostic applications. Another notable patent is "Anti-mGluR2 conformational single domain antibodies and uses thereof," which pertains to anti-metabotropic glutamate receptor subtype 2 (mGluR2) conformational single domain antibodies, also aimed at therapeutic and diagnostic uses.
Career Highlights
Throughout his career, Damien has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université d'Aix-Marseille. His research has been pivotal in advancing the understanding and application of antibodies in medicine.
Collaborations
Damien has collaborated with notable professionals in his field, including Daniel Baty and Patrick Chames. These partnerships have further enriched his research and innovation efforts.
Conclusion
Damien Nevoltris stands out as a key figure in the development of antibody technologies. His patents and collaborations reflect his commitment to advancing medical science through innovation.